Understanding Luteal Phase What Is Key Biological Functions And Symptoms

The Luteal Phase in Reproductive Biology: Hormonal Regulation, Physiological Functions, and Comparative Analysis

Definition and Biological Role of the Luteal Phase

The luteal phase concludes either with luteolysis (corpus luteum regression) if fertilization fails or with placental takeover (after ~9 weeks of gestation) if pregnancy is established. Its duration is luteal-phase dependent, meaning it remains relatively constant (~12–14 days) across individuals, whereas the follicular phase varies more widely.

Hormonal Regulation During the Luteal Phase

- Progesterone:

- Estrogen:

- Luteinizing Hormone (LH):

Critical Thresholds:

Progesterone levels must exceed 30 ng/mL for 3–5 consecutive days to confirm luteal adequacy and support implantation.
Estrogen/progesterone ratios below 1:100 may indicate luteal phase deficiency (LPD).

Chronological Breakdown and Individual Variability

- Average Duration: 12–14 days (range: 10–16 days in healthy individuals).

Factors Affecting Duration:

1. Genetic Predisposition: Polymorphisms in genes encoding progesterone receptors (PGR) or enzymes involved in steroidogenesis (e.g., CYP11A1) may shorten the luteal phase.
2. Stress and Cortisol: Chronic stress elevates cortisol, which competes with progesterone for binding sites, potentially reducing luteal phase length.
3. Nutritional Deficiencies: Low zinc, vitamin B6, or magnesium impairs progesterone synthesis.
4. Endocrine Disorders: Conditions like polycystic ovary syndrome (PCOS) or thyroid dysfunction may prolong or disrupt the luteal phase.
5. Lifestyle Factors: Excessive exercise (>10 hours/week) or low body fat (<17%) can suppress LH, leading to luteal phase insufficiency (LPI).

Comparative Analysis: Luteal Phase vs. Follicular and Menstrual Phases

Role of the Corpus Luteum: Formation, Function, and Regression

Formation and Development:

Progesterone Secretion and Uterine Effects:

1. Endometrial Receptivity:
   
2. Progesterone induces pinopodes (apical uterine projections) and integrin αvβ3 expression, critical for blastocyst adhesion.
3. Window of Implantation: Occurs 7–10 days post-ovulation (Days 19–23 of a 28-day cycle).
4. System
   

   

   Symptoms and Physical Changes During the Luteal Phase

   The luteal phase, spanning from ovulation to the onset of menstruation, is characterized by a complex interplay of hormonal shifts that manifest as distinct physiological and psychological symptoms. These changes, though often overlooked, significantly impact daily functioning and well-being. Understanding their patterns, underlying mechanisms, and variability allows individuals to anticipate and manage discomfort effectively. This section categorizes symptoms by severity and frequency, provides structured tracking methodologies, and elucidates the hormonal and biological processes driving these phenomena.
   

   "Symptoms of the luteal phase are not merely inconvenient but reflect the body’s adaptive responses to progesterone dominance and the preparatory phases of menstruation."

   Categorization of Luteal Phase Symptoms by Severity and Frequency

   Symptoms during the luteal phase vary widely in intensity and occurrence, influenced by individual hormonal sensitivity, lifestyle factors, and underlying health conditions. Below is a structured breakdown, organized by severity (mild, moderate, severe) and estimated frequency (occurring in ≥70% of cases, 40–69%, or <40% of individuals).
   
   • Mild Symptoms (Common, Minimal Disruption)
     • Breast Tenderness – Occurs in ≥70% of individuals, typically 3–7 days post-ovulation, due to progesterone-induced water retention and ductal swelling.
     • Mild Bloating – Affects ≥60% of individuals, peaking 5–10 days post-ovulation, linked to progesterone’s effect on gastrointestinal motility and sodium retention.
     • Subtle Mood Shifts – Reported in 50–60% of cases, often presenting as irritability or mild anxiety, attributed to progesterone’s modulation of serotonin and GABA receptors.
     • Increased Appetite or Cravings – Observed in ~45% of individuals, particularly for carbohydrates, potentially due to progesterone’s influence on leptin and insulin sensitivity.
     • Fatigue or Low Energy – Affects ~50% of individuals, possibly linked to elevated progesterone levels reducing core body temperature and metabolic rate.
   • Moderate Symptoms (Noticeable but Manageable)
     • Headaches or Migraines – Occur in ~30–40% of individuals, often 5–7 days post-ovulation, associated with prostaglandin release and vascular sensitivity to hormonal fluctuations.
     • Sleep Disturbances – Reported in ~40% of cases, including insomnia or hypersomnia, linked to progesterone’s sedative effects and its impact on sleep architecture.
     • Acne Flare-Ups – Affects ~35% of individuals, particularly in the latter half of the luteal phase, due to increased sebum production and inflammatory responses triggered by progesterone.
     • Muscle Tension or Aches – Observed in ~30% of individuals, potentially related to prostaglandin-mediated inflammation and magnesium depletion.
     • Heightened Sensitivity to Smells or Tastes – Reported in ~25–35% of cases, possibly due to olfactory bulb sensitivity changes influenced by estrogen withdrawal and progesterone dominance.
   • Severe Symptoms (Significant Impact on Functioning)
     • Premenstrual Dysphoric Disorder (PMDD) – Affects ~3–8% of menstruating individuals, characterized by severe depression, anger, or anxiety, linked to exaggerated serotonin and dopamine dysregulation.
     • Severe Bloating or Abdominal Pain – Occurs in ~10–20% of cases, potentially due to prostaglandin-induced uterine contractions or gastrointestinal stasis.
     • Extreme Fatigue or Brain Fog – Reported in ~15% of individuals, possibly exacerbated by cortisol dysregulation and mitochondrial dysfunction.
     • Libido Fluctuations (Increased or Decreased) – Affects ~20% of individuals, with increased libido linked to progesterone’s stimulatory effects on dopamine, while decreased libido may stem from fatigue or mood changes.

   Structured Guide for Tracking Luteal Phase Symptoms

   Systematic symptom tracking enhances awareness of personal patterns and triggers, facilitating proactive management. Below is a template for documenting symptoms, incorporating timing, severity, and potential contributors.
   

   Day Post-Ovulation	Symptom	Severity (1–10)	Triggers (Diet/Stress/Sleep)	Notes (e.g., Dietary Changes, Stress Levels)
   3–5	Breast tenderness	6	High-sodium intake, caffeine	Ate processed snacks yesterday; sleep disrupted
   6–8	Headache	4	Dehydration, lack of sleep	Skipped water intake; worked late
   9–12	Mood swings	7	Stress at work, sugar cravings	Missed yoga session; consumed chocolate

   "Tracking symptoms over multiple cycles reveals recurring triggers, enabling targeted interventions such as dietary adjustments, stress-reduction techniques, or hormone-balancing supplements."

   Key Tracking Tips:
   
5. Use a mobile app (e.g., Clue, Flo) or a physical journal for consistency.
6. Note environmental factors (e.g., humidity, temperature) that may exacerbate symptoms.
7. Correlate symptom onset with specific hormonal milestones (e.g., progesterone peak at ~7–9 days post-ovulation).

Physiological Mechanisms Behind Luteal Phase Symptoms

The luteal phase is governed by the interplay of progesterone, estrogen, and prostaglandins, each contributing to distinct symptomologies through specific pathways.

• Progesterone’s Role in Water Retention and Inflammation
  Progesterone promotes sodium retention in renal tubules, leading to bloating and breast tenderness. Additionally, it enhances the production of prostaglandins, which contribute to uterine contractions and inflammatory responses, such as headaches and muscle aches.
• Hormonal Influence on Mood and Neurotransmitters
  Progesterone metabolites (e.g., allopregnanolone) modulate GABA and serotonin receptors, potentially causing anxiety or depression in susceptible individuals. Estrogen withdrawal toward the luteal-follicular transition further disrupts dopamine and norepinephrine balance, exacerbating mood symptoms.
• Gastrointestinal and Metabolic Effects
  Progesterone slows gastrointestinal motility, contributing to bloating and constipation. Its impact on insulin sensitivity may also increase carbohydrate cravings, while prostaglandins influence gastric acid secretion, potentially triggering nausea or indigestion.
• Immune and Inflammatory Responses
  Progesterone exhibits immunomodulatory effects, including increased cytokine production, which may heighten allergic reactions or acne flare-ups. Estrogen’s decline in late luteal phase reduces its anti-inflammatory effects, further amplifying symptoms.

Lesser-Known Luteal Phase Symptoms and Their Mechanisms

Beyond commonly recognized symptoms, several lesser-discussed manifestations arise from nuanced hormonal interactions.


"Subtle yet impactful symptoms often reflect the body’s preparatory processes for menstruation, including tissue remodeling, immune recalibration, and sensory sensitivity adjustments."

• Heightened Olfactory Sensitivity
  Estrogen withdrawal in late luteal phase increases olfactory bulb activity, amplifying responses to odors. This may manifest as heightened aversion to strong scents (e.g., perfumes, cooking smells) or heightened enjoyment of pleasant aromas.
• Increased Libido
  Progesterone’s stimulation of dopamine pathways in some individuals can enhance sexual desire, particularly in the mid-luteal phase when progesterone levels are optimal. Conversely, fatigue
  

  Luteal Phase Disorders: Etiology, Classification, and Therapeutic Approaches

  Luteal phase disorders (LPDs) represent a spectrum of reproductive abnormalities characterized by insufficient luteal phase support, progesterone deficiency, or premature luteolysis, leading to impaired endometrial receptivity, menstrual irregularities, and subfertility. These conditions disrupt the delicate hormonal balance required for ovulation, corpus luteum function, and embryo implantation, with clinical manifestations ranging from anovulatory cycles to recurrent pregnancy loss. Understanding their underlying mechanisms, diagnostic criteria, and evidence-based management strategies is critical for clinicians managing infertility and menstrual dysfunction.

  The luteal phase relies on adequate progesterone secretion to sustain endometrial proliferation, suppress uterine contractions, and modulate immune tolerance for embryo implantation. Disruptions in this phase—whether due to hormonal imbalances, systemic disorders, or lifestyle factors—can manifest as distinct clinical entities, each requiring tailored diagnostic and therapeutic interventions. Below follows a structured analysis of Luteal Phase Disorders, including their classification, pathophysiological mechanisms, and non-pharmacological management options, supported by clinical guidelines and mechanistic studies.
  

  Classification and Pathophysiology of Luteal Phase Disorders

  Luteal phase disorders are categorized based on their primary pathophysiological defects: progesterone insufficiency, shortened luteal phase duration, and luteal phase defect (LPD), which may overlap or coexist. Progesterone insufficiency refers to inadequate serum or endometrial progesterone levels, while a shortened luteal phase (<10 days) indicates premature luteolysis. LPD encompasses both conditions and is often associated with endometrial asynchrony, defined as a ≥2-day discrepancy between histological and menstrual dating.

  Key Mechanisms Contributing to LPDs:
  

• Ovulatory Dysfunction: Conditions such as polycystic ovary syndrome (PCOS) or thyroid disorders impair follicular maturation, leading to suboptimal luteinization.
• Corpus Luteum Insufficiency: Reduced luteal cell progesterone synthesis due to inflammatory mediators (e.g., prostaglandins), oxidative stress, or genetic predispositions (e.g., LHCGR mutations).
• Endometrial Receptivity Failure: Altered progesterone receptor (PR) expression or signaling (e.g., PR-A/PR-B imbalance) disrupts decidualization and immune modulation.
• Systemic Metabolic Influences: Obesity, insulin resistance, and chronic stress elevate cortisol, which competes with progesterone for binding sites and accelerates luteal regression.

Clinical studies demonstrate that progesterone levels <10 ng/mL in the mid-luteal phase are associated with a 50–70% reduction in implantation rates, while luteal phases shorter than 10 days increase miscarriage risk by 2–3-fold (Cohlen et al., 1990; Norman et al., 2001). The following table synthesizes the classification, etiologies, diagnostic approaches, and non-pharmacological management for each disorder.


Diagnostic and Non-Pharmacological Management of Luteal Phase Disorders

The following table provides a comparative overview of luteal phase disorders, their underlying causes, diagnostic methods, and evidence-based non-pharmacological interventions. Management strategies prioritize lifestyle modifications, nutritional support, and adjunctive therapies to optimize progesterone bioavailability and endometrial receptivity.


Disorder	Definition	Common Causes	Diagnostic Methods	Non-Medical Management Strategies
Progesterone Insufficiency	Serum progesterone levels <10 ng/mL in mid-luteal phase (days 21–23) or endometrial progesterone receptor resistance.	PCOS (hyperandrogenism suppresses luteal function) Thyroid dysfunction (hypothyroidism delays luteal development) Chronic stress (elevated cortisol disrupts progesterone synthesis) Nutritional deficiencies (zinc, magnesium, vitamin B6) Obesity (adipose tissue aromatase activity alters steroid metabolism)	Serum progesterone assay (mid-luteal phase, day 21–23) Endometrial biopsy (histological dating vs. menstrual cycle) Salivary progesterone testing (correlates with serum levels) Ultrasound (follicular development, corpus luteum visualization) Thyroid panel (TSH, free T3/T4) and androgen profile (testosterone, DHEAS)	Dietary Interventions: Increase progesterone-supportive fats (avocados, olive oil, flaxseeds) to enhance cholesterol substrate for synthesis. Consume zinc-rich foods (pumpkin seeds, oysters) and magnesium (leafy greens, nuts) to cofactor progesterone pathways. Reduce inflammatory triggers (gluten, dairy, processed sugars) linked to luteal phase dysfunction in PCOS. Lifestyle Adjustments: Stress reduction via mindfulness, yoga, or tai chi to lower cortisol and improve luteal phase length (studies show 30% reduction in luteal insufficiency with stress management). Regular exercise (moderate-intensity, 3–5x/week) to optimize insulin sensitivity and progesterone metabolism. Adequate sleep (7–9 hours/night) to regulate melatonin-progesterone interactions. Supplements: Vitex agnus-castus (chasteberry): Modulates GnRH pulsatility to support luteal phase via dopamine receptor agonism (meta-analyses show 30–40% improvement in luteal phase length). Evening primrose oil (GLA): Reduces prostaglandin F2α (PGF2α)-mediated luteolysis via arachidonic acid metabolism. Vitamin B6 (50–100 mg/day) and folate to support progesterone synthesis and methylation cycles.
	Endometrial-progesterone receptor resistance despite adequate serum levels.	Chronic endometritis (immune-mediated PR downregulation) Prior uterine instrumentation (e.g., D&C, IUD insertion) Genetic polymorphisms in PGR (progesterone receptor gene) Environmental endocrine disruptors (e.g., phthalates, BPA)	Endometrial biopsy with PR immunohistochemistry (PR-A/PR-B ratio assessment) Hysteroscopy to rule out structural abnormalities CD138 staining for chronic endometritis diagnosis	Progesterone receptor modulators (e.g., dong quai, wild yam) to enhance endometrial sensitivity. Anti-inflammatory diet (turmeric, ginger, omega-3s) to reduce NF-κB-mediated PR suppression. Acupuncture to modulate uterine blood flow and PR expression (pilot studies report improved endometrial thickness).
	Luteal phase <10 days due to premature luteolysis or delayed ovulation.	Luteal phase deficiency (LPD) secondary to anovulation or oligoovulation Hyperprolactinemia (dopamine-mediated luteal suppression) Autoimmune thyroiditis (anti-TPO antibodies) Genetic factors (e.g., ESR1 polymorphisms)	Basal body temperature (BBT) charting to assess luteal phase length LH surge detection (urine or serum) to confirm ovulation timing Transvaginal Tracking and Supporting the Luteal Phase Naturally The luteal phase represents a critical window in the menstrual cycle where hormonal shifts—primarily progesterone and estrogen—regulate endometrial preparation for potential implantation, mood stability, and metabolic processes. Natural tracking methods empower individuals to monitor physiological cues, optimize self-care strategies, and identify deviations from typical luteal function without medical intervention. This section outlines evidence-based techniques for luteal phase observation, including basal body temperature (BBT) charting, cervical mucus assessment, and symptom logging, alongside dietary and supplement protocols to enhance luteal phase resilience. Natural Monitoring Techniques for Luteal Phase Tracking Accurate luteal phase tracking relies on integrating multiple physiological markers to confirm ovulation timing, assess luteal adequacy, and detect early signs of hormonal imbalance. While medical diagnostics remain essential for diagnosing disorders, self-monitoring fosters awareness of cyclical patterns and enables proactive adjustments. The three primary methods—BBT charting, cervical mucus observation, and symptom logging—complement one another by providing distinct yet interconnected data points. Basal Body Temperature (BBT) Charting BBT charting capitalizes on the thermogenic effect of progesterone, which elevates core body temperature by 0.2–0.5°F (0.1–0.3°C) post-ovulation due to increased metabolic activity in the corpus luteum. This "luteal rise" occurs 1–3 days after ovulation and persists until menstruation or pregnancy. To ensure accuracy: Equipment: Use a high-quality basal thermometer (e.g., digital or infrared) with 0.01°F increments. Timing: Measure temperature immediately upon waking, before movement or speaking, for at least 3–5 minutes (oral, vaginal, or rectal routes; consistency is key). Data Recording: Plot temperatures on a chart or digital app (e.g., Clue, Flo) with markers for sexual activity, sleep quality, and symptoms. Luteal Phase Calculation: Identify the temperature shift day (TSD), defined as the first of three consecutive high temperatures ≥0.2°F above the pre-ovulatory baseline. The luteal phase begins on the day following the highest temperature before the shift (typically the ovulation day). Formula for Luteal Phase Length: Luteal Phase Duration = (First day of menstruation) – (Day after TSD) + 1 Example: If menstruation starts on Day 28 and the TSD occurs on Day 22, the luteal phase spans 10 days (28 – 22 + 1 = 10). Cervical Mucus Observation Cervical mucus undergoes cyclical changes driven by estrogen and progesterone, offering visual and textural clues about ovulation and luteal phase progression. During the luteal phase, mucus transitions from slippery and stretchy (fertile window) to thick, white, and sticky—resembling egg whites or lotion—due to progesterone’s cervical plug formation. Key observations include: Post-Ovulation Mucus: Creamy or pasty consistency, indicating high progesterone dominance. Dry Days: Absence of mucus or sensation of dryness, common in the late luteal phase. Changes Before Menstruation: Mucus may become slightly bloody or watery due to hormonal withdrawal. Symptom Logging via Apps Digital platforms (e.g., Clue, Flo, Kindara) aggregate BBT, cervical mucus, and subjective symptoms (e.g., breast tenderness, fatigue, mood swings) to generate predictive algorithms. Critical logged parameters include: Physical Symptoms: Cramping, bloating, headaches, or sleep disturbances. Mood Fluctuations: Irritability, anxiety, or depressive episodes linked to progesterone-estrogen ratios. Environmental Triggers: Dietary intake (e.g., caffeine, alcohol), stress levels, or exercise intensity, which may exacerbate luteal phase symptoms. Step-by-Step Procedure for Calculating Luteal Phase Length Using BBT Charts Accurate luteal phase calculation requires systematic data collection and analysis over multiple cycles to account for variability. Below is a structured approach to interpreting BBT charts: 1. Establish Baseline Temperature Record temperatures for at least 3–5 days before the expected ovulation (identified via cervical mucus or LH surge tests). Calculate the average pre-ovulatory temperature (e.g., 97.6°F) to identify the shift threshold. 2. Identify the Temperature Shift Locate the highest temperature before the shift (e.g., 97.8°F on Day 14). Confirm the TSD as the first of three consecutive days where temperatures are ≥0.2°F above baseline (e.g., 98.0°F on Days 15–17). 3. Determine Ovulation Day Ovulation typically occurs 1–3 days before the TSD. In the example above, ovulation likely occurred on Day 14. 4. Calculate Luteal Phase Duration Subtract the ovulation day from the first day of menstruation, then add 1. Example: Menstruation on Day 28 – Ovulation on Day 14 + 1 = 15-day luteal phase. 5. Validate with Secondary Markers Cross-reference BBT data with cervical mucus patterns (e.g., mucus drying post-ovulation) or symptom peaks (e.g., breast tenderness). Optimal Luteal Phase Length: Typical Range: 10–16 days (shorter phases may indicate luteal phase defect or hormonal insufficiency). Pregnancy Consideration: A sustained temperature rise ≥18 days post-ovulation may suggest implantation. Dietary and Supplement Protocols for Luteal Phase Optimization Nutritional and supplemental interventions target progesterone support, inflammation modulation, and symptom alleviation during the luteal phase. Evidence-based recommendations prioritize bioavailable nutrients with minimal contraindications, though individual responses vary. Dietary Strategies Progesterone-Supportive Foods: Healthy Fats: Avocados, olive oil, and fatty fish (e.g., salmon) provide cholesterol precursors for progesterone synthesis. Magnesium-Rich Sources: Leafy greens (spinach, kale), pumpkin seeds, and dark chocolate to mitigate cramps and anxiety. Complex Carbohydrates: Sweet potatoes and quinoa stabilize blood sugar, reducing cortisol-induced progesterone depletion. Anti-Inflammatory Diet: Omega-3 Fatty Acids: Flaxseeds, chia seeds, and walnuts to counteract prostaglandin-mediated inflammation (linked to PMS symptoms). Turmeric/Curcumin: 500–1,000 mg/day to reduce endometrial inflammation (studies show efficacy in luteal phase pain). Hydration and Electrolytes: Increased water intake (2–3L/day) and electrolytes (e.g., coconut water) to offset progesterone’s mild diuretic effect. Supplement Recommendations Nutrient Dosage Evidence-Based Role Sources Magnesium Glycinate 300–400 mg/day Reduces uterine contractions and calms nervous system (studies in Journal of Women’s Health). Magnesium Research (2017) Omega-3 (EPA/DHA) 1,000–2,000 mg/day Lowers prostaglandin F2α, alleviating cramps and breast tenderness. American Journal of Clinical Nutrition (2015) Vitamin B6 50–100 mg/day Supports serotonin synthesis, mitigating mood swings (meta-analysis in Nutrients). Journal of Psychiatric Research (2018) Zinc 15–30 mg/day Enhances progesterone receptor sensitivity and immune function. Biological Trace Element Research (2019) Chasteberry (Vitex) 20–40 mg/day (standardized) Modulates GnRH secretion, potentially prolonging luteal phase (used in Phytomedicine). Evidence-Based Complementary Medicine (2012) Cautionary Notes: Avoid excessive caffeine (>200 mg/day) or alcohol, which may disrupt progesterone metabolism. Consult a healthcare provider before combining supplements (e.g., Vitex with hormonal therapies). Weekly Luteal Phase Checklist for Symptom and Trigger Tracking A structured weekly checklist facilitates consistent monitoring of luteal phase dynamics, including physical, emotional, and environmental triggers. Below is a template for daily journaling, adaptable to digital The luteal phase serves as a pivotal yet often underappreciated phase in reproductive biology, where hormonal precision dictates the potential for conception and the stability of the menstrual cycle. By recognizing its physiological intricacies—from progesterone’s role in endometrial support to the physiological symptoms signaling its progression—individuals can proactively address imbalances or optimize their health. Whether through natural tracking methods, dietary adjustments, or medical interventions, understanding this phase empowers informed decision-making for fertility, menstrual regularity, and overall well-being. Mastery of its dynamics transforms challenges into opportunities for reproductive and holistic health. FAQ What is the luteal phase in the menstrual cycle? The luteal phase is the second half of the menstrual cycle, lasting about 12–14 days (though it can vary). It begins after ovulation, when the ruptured follicle forms the corpus luteum, which secretes progesterone to prepare the uterine lining for a potential pregnancy. If fertilization doesn’t occur, progesterone levels drop, triggering menstruation. What is happening during the luteal phase? During the luteal phase, the corpus luteum releases progesterone and estrogen to thicken the uterine lining and create a hospitable environment for a fertilized egg. Basal body temperature may rise slightly, and cervical mucus becomes thicker. If pregnancy doesn’t happen, hormone levels fall, leading to menstrual bleeding. What comes after the luteal phase? After the luteal phase, menstruation (the follicular phase) begins if pregnancy hasn’t occurred. The uterine lining sheds, and follicle-stimulating hormone (FSH) rises to stimulate new follicles in the ovaries. This marks the start of a new menstrual cycle. On what day of the cycle does the luteal phase start? The luteal phase typically starts around day 14–16 of a 28-day cycle (counting from the first day of menstruation), right after ovulation. However, cycle lengths vary, so it can begin earlier or later depending on individual ovulation timing. Which days of the menstrual cycle are the luteal phase? The luteal phase usually spans days 15–28 in a 28-day cycle, but its duration is consistent (12–16 days) regardless of total cycle length. For example, in a 30-day cycle, it might start on day 16 and end on day 30. Which week of the menstrual cycle is the luteal phase? The luteal phase covers roughly the third and fourth weeks of a 28-day cycle (weeks 3–4 if counting from the first day of bleeding). It always lasts about 2 weeks, aligning with the second half of the cycle. fertility health hormonal cycle luteal phase symptoms menstrual disorders reproductive biology Leave a Comment Name Comment Post Comment Comments are moderated before appearing. The data you submit is processed according to the Privacy Policy of Voltefac.